Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis. Today, our panel of experts will explore the treatment landscape and impact of multiple sclerosis ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Multiple Sclerosis Market and Competitive Landscape Highlights - 2016" report to their offering. The latest ...
Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.
Cladribine, a nucleotide (deoxyadenosine) analogue, inhibits deoxyribonucleic acid (DNA) synthesis in proliferating lymphocytes, causing DNA damage and depleting their number by apoptosis and ...
DelveInsight's “Multiple Sclerosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Multiple Sclerosis, historical and forecasted epidemiology ...
In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...
Researchers have identified the first genetic marker of multiple sclerosis severity. The genetic variant was seen in people who experienced quicker progression of the disease, resulting in greater ...
When you live with multiple sclerosis (MS), the foods you eat can make a significant difference in your overall health. No specific diet can treat or cure MS, but many people find relief from symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results